Related Experiment Video

Updated: Aug 14, 2026

Measurement of 3-Dimensional cAMP Distributions in Living Cells using 4-Dimensional (x, y, z, and λ) Hyperspectral FRET Imaging and Analysis
08:22

Measurement of 3-Dimensional cAMP Distributions in Living Cells using 4-Dimensional (x, y, z, and λ) Hyperspectral FRET Imaging and Analysis

Published on: October 27, 2020

Compartmentalized phosphodiesterase-2 activity blunts beta-adrenergic cardiac inotropy via an NO/cGMP-dependent

Marco Mongillo1, Carlo G Tocchetti, Anna Terrin

  • 1Dulbecco Telethon Institute, Venetian Institute of Molecular Medicine, Padova, Italy.

Circulation Research
|December 17, 2005
PubMed

Insights

Phosphodiesterases (PDEs) regulate heart cell signaling. PDE2 specifically controls cyclic AMP (cAMP) levels in response to catecholamines, influencing cardiac function through a novel beta-adrenergic pathway.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cell Biology
  • Biochemistry

Background:

  • Beta-adrenergic signaling regulates cardiac function via cAMP and PKA.
  • Precise control of cAMP signaling is crucial for cardiac cell specificity.
  • Phosphodiesterases (PDEs) degrade cAMP, controlling intracellular gradients.

Purpose of the Study:

  • To investigate the role of PDEs in shaping cAMP responses to catecholamines in cardiac cells.
  • To elucidate the specific contribution of PDE2 in beta-adrenergic signaling pathways.
  • To understand the interplay between cAMP, cGMP, and nitric oxide (NO) in cardiac myocytes.

Main Methods:

  • Real-time imaging of cyclic nucleotides in living ventriculocytes.
  • Investigating signaling pathways involving beta-adrenergic receptors, NO, and cGMP.
  • Analyzing the functional coupling of PDE2 to adenylyl cyclase activity.

Main Results:

  • PDE2 plays a key role in selectively modulating catecholamine-induced cAMP responses.
  • A pathway involving beta3-adrenergic receptors, NO, and cGMP influences PDE2 activity.
  • PDE2 coordinates cGMP and cAMP signaling, forming a feedback loop in the beta-adrenergic pathway.

Conclusions:

  • Compartmentalized PDE2 is critical for controlling catecholamine-generated cAMP in cardiac myocytes.
  • Beta3-adrenergic receptor activation, via NO and cGMP, counteracts cAMP generation from beta1/beta2-adrenoceptors.
  • This study advances the understanding of localized cAMP signaling and its regulation by PDE2.

More Related Videos

Contractility Measurements on Isolated Papillary Muscles for the Investigation of Cardiac Inotropy in Mice06:22

Contractility Measurements on Isolated Papillary Muscles for the Investigation of Cardiac Inotropy in Mice

Published on: September 17, 2015

Real-Time cAMP Dynamics in Live Cells Using the Fluorescent cAMP Difference Detector In Situ06:03

Real-Time cAMP Dynamics in Live Cells Using the Fluorescent cAMP Difference Detector In Situ

Published on: March 22, 2024

Related Concept Videos

G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...